Adaptive Biotechnologies to report Q1 2026 financial results on May 5, 2026

Adaptive Biotechnologies, a biotech company focused on immune system-based diagnostics and treatments, will announce its first quarter 2026 financial results after market close on May 5, 2026. The company will host a webcast conference call at 1:30 p.m. PT to discuss the results. This update is important as it provides insight into the company's progress in developing immune-driven clinical products for diseases like cancer and autoimmune disorders. Investors can access the live webcast on the company's website and replay it within 24 hours.